Swissmedic carried out systematic, focused inspections of Swiss authorized representatives (CH-REP) in the first half of 2022 to check their implementation of the provisions in the market.
In most cases, the authorized representatives demonstrated a good understanding of the new regulations and satisfactory implementation of the legal requirements.
No deviations were found for six of the 20 authorized representatives inspected. The non-conformities found for 14 authorized representatives included: